Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
State Health Facts is a KFF project that provides free, up-to-date, and easy-to-use health data for all 50 states, the District of Columbia, and the United States. It offers data on specific types of health insurance coverage, including employer-sponsored, Medicaid, Medicare, as well as people who are uninsured by demographic characteristics, including age, race/ethnicity, work status, gender, and income. There are also data on health insurance status for a state's population overall and broken down by age, gender, and income.
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis of 2024 federal plan data.
The unwinding of pandemic enrollment protections in Medicaid helped accelerate states’ expansion of eligibility for key groups and adoption of policy and system changes to streamline renewal processes for enrollees, according to findings from a new KFF survey of state Medicaid officials.
This issue brief examines the most recent trends in children’s routine vaccinations, including COVID-19, and explores what to watch as children head back to school this year.
Oral contraceptives are the most commonly used method of reversible contraception in the U.S. In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.
Addressing health care needs of people moving into and out of the criminal justice system and staff who work them is an important component of coronavirus response efforts and protecting and promoting public health within the communities in which correctional facilities are located. This brief provides data on spread of coronavirus within correctional facilities, discusses the health risks for the justice-involved population and the staff who work with them, identifies the role Medicaid can play in response efforts for justice-involved individuals, and highlights other steps correctional systems can take to mitigate risk of coronavirus for the justice-involved population and promote public health.
New analysis of KFF’s 2019 Employer Benefits Survey finds that 10% of workers covered by employer-sponsored health insurance are employed at a firm that has asked their insurer or third party administrator to exclude abortion coverage from their health plan.
Coverage Losses Will Affect At Least a Million Residents in Each of Eight States: California, Texas, Pennsylvania, New York, Georgia, Florida, Michigan and Ohio With more than 31 million workers filing unemployment claims between March 1 and May 2 as the coronavirus crisis hit the nation’s economy, a new KFF analysis estimates 26.
In this May 2020 post for The JAMA Health Forum, Larry Levitt explores how the massive and rapid job losses of the past few months will test the ACA’s coverage safety net – and how different policies could strengthen or weaken it.
Roughly 3.4 million individuals work in food production industries, more than a third of them in animal production and processing where there have been several COVID-19 outbreaks, a new KFF analysis shows. Workers at meat and poultry plants face a higher risk of coronavirus exposure due to the close quarters of their workplaces.
Surprisingly, in comparison to the nearly 9% drop in employment from March to June, early data suggests that employers had kept coverage rates remarkably steady, at least through mid-summer. We find that enrollment in the fully-insured group market dropped by just 1.3% from the end of March through the end of June.
© 2025 KFF
